Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.

CONCLUSIONS: TFAP2B expression may be a potential prognostic molecular marker of poor survival in endometrial cancer, Moreover, the p53/hypoxia, androgen response and notch signaling pathway may be the key pathway regulated by TFAP2B in EC.
PMID: 29602546 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - March 28, 2018 Category: Cancer & Oncology Authors: Wu H, Zhang J Tags: Gynecol Oncol Source Type: research